Alcon and RxSight announce collaboration to develop adjustable PCIOLs
The non-exclusive agreement aims to combine Alcon's PCIOL optics with RxSight's light-adjustable platform for post-surgery vision fine-tuning.
See the latest news and media coverage for Alcon. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of eye care products and surgical equipment
alcon.comLast updated
In short: Alcon delivered strong financial growth and launched several key surgical and vision care innovations despite terminating major mergers.
The non-exclusive agreement aims to combine Alcon's PCIOL optics with RxSight's light-adjustable platform for post-surgery vision fine-tuning.
The report highlights exceeding goals in children's vision screenings, cataract care, R&D investment, and emissions reductions.
The awards honor innovation in Health, Medical & Biotech. Recognition reflects team collaboration and dedication.
Sales reach $2.7 billion, up 10%; core EPS $0.85. New products like Unity and Tryptyr drive growth. $1.5B share repurchase authorized.
Alcon is expected to comment on the business results of the quarter ended June 30, 2026, on August 10, 2026. The forecasts of 18 analysts amount for the latest...
The Eurozone benchmark index EuroStoxx 50 fell 0.31 percent to 6,245.97 points by midday. Outside the euro area, the British FTSE 100 fell 0.38 percent to...
We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Alcon Inc. (NYSE:ALC) is one of the best healthcare stocks...
Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies; Collaboration aims to combine best-in-class...
Track Alcon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.